Contribution of humoral immunity to the therapeutic response in falciparum malaria

American Journal of Tropical Medicine and Hygiene

Volumn 65, Issue 6, 2001, Pages 918-923

  Mayxay, M ^a   Chotivanich, K ^a   Pukrittayakamee, S ^a   Newton, P ^a   Looareesuwan, S ^a   White, N J ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; ARTESUNATE; AZITHROMYCIN; BENFLUMETOL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTOZOON ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; INFECTION RESISTANCE; MALARIA FALCIPARUM; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0035680951     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2001.65.918     Document Type: Article

References (21)

1. Observations on malaria made during treatment of general paralysis
2. Antibodies in malaria sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum
3. In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria
4. The mechanisms of parasite clearance following antimalarial treatment of Plasmodium falciparum malaria
5. A longitudinal study of antibodies to the Plasmodium falciparum antigen Pf155/RESA and immunity to malaria infection in adult Liberians
6. A longitudinal study of sero-reactivities to Pf155/RESA and its repetitive sequences in small children from a holoendemic area of Liberia
7. Antibodies to ring-infected erythrocyte surface antigen (Pf155/RESA) protect against P. falciparum parasitaemia in highly exposed multigravidae women in Malawi
8. A longitudinal study of seroreactivities to a major blood stage antigen (Pf155/RESA) of the malaria parasite Plasmodium falciparum in an endemic area of Thailand
9. Humoral response to Plasmodium falciparum ring-infected erythrocyte surface antigen in a highly endemic area of Papua New Guinea
10. Antibodies to sequences in a non-repeat region of Plasmodium falciparum antigen Pf155/RESA inhibit either cytoadherence or parasite growth in vitro
11. Inhibition of in vitro growth of Plasmodium falciparum field isolates mediated by human antibodies to Pf155/RESA and Pf332
12. Human monoclonal antibodies to Pf155, a major antigen of malaria parasite Plasmodium falciparum
13. Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers
14. Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria
15. Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children
16. Severe and complicated malaria
17. Human malaria parasites in continuous culture
18. Anti-Plasmodium falciparum antibodies acquired by residents in a holoendemic area of Liberia during development of clinical immunity
19. Possible role of specific immunoglobulin M antibodies to Plasmodium falciparum antigens in immunoprotection of humans living in a hyperendemic area, Burkina Faso
20. Impairment of Plasmodium falciparum specific antibody response in severe malaria
21. Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: A prospective study in a malaria-endemic region of West Africa